F2R and gastric cancer: Furthermore, EPCR and PAR-1 are co-expressed in gastric cancer (GC) cells, where EPCR exerts pro-carcinogenic effects by inducing PAR-1-dependent ERK1/2-MAPK pathway signaling to ultimately regulate proliferation and migration of tumor cells.